Similar articles

• Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.

  Schaapveld M, Aleman BM, van Eggermond AM, Janus CP, Krol AD, van der Maazen RW, Roesink J, Raemaekers JM, de Boer JP, Zijlstra JM, van Imhoff GW, Petersen EJ, Poortmans PM, Beijert M, Lybeert ML, Mulder I, Visser O, Louwman MW, Krul IM, Lugtenburg PJ, van Leeuwen FE. Schaapveld M, et al. N Engl J Med. 2015 Dec 24;373(26):2499-511. doi: 10.1056/NEJMoa1505949. N Engl J Med. 2015. PMID: 26699166
• The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.

  Brusamolino E, Anselmo AP, Klersy C, Santoro M, Orlandi E, Pagnucco G, Lunghi F, Maurizi-Enrici R, Baroni CD, Lazzarino M, Mandelli F, Bernasconi C. Brusamolino E, et al. Haematologica. 1998 Sep;83(9):812-23. Haematologica. 1998. PMID: 9825578
• [Second malignant disease in patients under treatment for malignant lymphoma].

  Várady E, Molnár Z, Schneider T, Fleischmann T. Várady E, et al. Orv Hetil. 1995 Oct 22;136(43):2323-8. Orv Hetil. 1995. PMID: 7478476 Review. Hungarian.
• Second lethal events associated with treatment for Hodgkin's disease: a review of 2980 patients treated in a single Mexican institute.

  Avilés A, Neri N, Cuadra I, Alvarado I, Cleto S. Avilés A, et al. Leuk Lymphoma. 2000 Oct;39(3-4):311-9. doi: 10.3109/10428190009065830. Leuk Lymphoma. 2000. PMID: 11342311
• Long-term endocrine side effects of childhood Hodgkin's lymphoma treatment: a review.

  van Dorp W, van Beek RD, Laven JS, Pieters R, de Muinck Keizer-Schrama SM, van den Heuvel-Eibrink MM. van Dorp W, et al. Hum Reprod Update. 2012 Jan-Feb;18(1):12-28. doi: 10.1093/humupd/dmr038. Epub 2011 Sep 6. Hum Reprod Update. 2012. PMID: 21896559 Review.